Trichostatin A Induces Apoptotic Cell Death in Human Breast Carcinoma Cells through Activation of Caspase-3

  • Kim, Nsm-Deuk (Department of Pharmacy, Pusan National University and Pusan Cancer Research Center) ;
  • Kim, Seaho (Department of Biochemistry, College of Oriental Medicine, Dong-Eui University and Research Center for Oriental Medicine) ;
  • Choi, Yung-Hyun (Department of Pharmacy, Pusan National University and Pusan Cancer Research Center) ;
  • Im, Eun-Ok (Department of Pharmacy, Pusan National University and Pusan Cancer Research Center) ;
  • Lee, Ji-Hyeon (Department of Chemistry, Inje University) ;
  • Kim, Dong-Kyoo (Department of Pharmacy, Pusan National University and Pusan Cancer Research Center)
  • Published : 2000.12.01

Abstract

Trichostatin A (TSA) is a Streptomyces product, which inhibits the enzyme activity of histone deacetylase. It is also known as an inducer of apoptosis in several human cancer cell lines. In this study, we investigated the mechanism of apoptosis induced by TSA in MDA-MB-231 human breast carcinoma cells. The cytotoxicity of TSA on MDA-MB-231 cells was assessed by MTT assay. The cell viability was decreased dose-dependently and the IC\ulcorner value was about 100 ng/ml after 48 h treatment with TSA. Morphological change and DNA ladder formation, the biochemical hallmarks of apoptotic cell death, were observed after treatment of TSA in a concentration-dependent manner, which was accompanied with cleavage of poly(ADP-ribose) polymerase and $\beta$-catenin, and activation of caspase-3. TSA treatment up-regulated the expression of a cyclin-dependent kinase inhibitor p21 (Wafl/Cip1) protein, a key regulatory protein of the cell cycle. However, there is no detectable change of both Bcl-2 and Bax expressions. These results demonstrated that TSA might inhibit cell growth through apoptosis in human breast carcinoma MDA-MB-231 cells.

Keywords